South Korea's Health Ministry Unveils Provisions For November's Anti-rebate Law
This article was originally published in PharmAsia News
SEOUL - South Korea's Ministry of Health and Welfare outlined detailed provisions to implement a new "anti-rebate law," which will enable courts to punish both contributors and receivers of rebates. Passed overwhelmingly by South Korea's National Assembly on April 28, the law goes into effect Nov. 28, and will be enforced by the ministry.Under the new regulations, pharmas will be able to offer "sample" drugs as long as they are offered the "minimum packing unit," said the ministry, adding that they will also be able to offer minimal amounts of drugs and research fees to those conducting clinical trials
You may also be interested in...
Korea’s Health Ministry Tightens Grip On Healthcare Professionals And Companies For Illegal Marketing
Draft regulation would increase license suspensions for healthcare professionals, and puts companies at greater risk of losing sales licenses and entire distribution offices.
With the help of state prosecutors, Korea’s health ministry expands the scope of anti-rebate surveillance to the medical device sector.
After a year on the books, Korea’s new anti-rebate law nabs its first healthcare professional.